These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
269 related articles for article (PubMed ID: 23116313)
1. Delivery of curcumin and medicinal effects of the copper(II)-curcumin complexes. Leung MH; Harada T; Kee TW Curr Pharm Des; 2013; 19(11):2070-83. PubMed ID: 23116313 [TBL] [Abstract][Full Text] [Related]
2. Recent progress in studying curcumin and its nano-preparations for cancer therapy. Liu J; Chen S; Lv L; Song L; Guo S; Huang S Curr Pharm Des; 2013; 19(11):1974-93. PubMed ID: 23116308 [TBL] [Abstract][Full Text] [Related]
3. A review of therapeutic effects of curcumin. Noorafshan A; Ashkani-Esfahani S Curr Pharm Des; 2013; 19(11):2032-46. PubMed ID: 23116311 [TBL] [Abstract][Full Text] [Related]
4. Oral bioavailability of curcumin: problems and advancements. Liu W; Zhai Y; Heng X; Che FY; Chen W; Sun D; Zhai G J Drug Target; 2016 Sep; 24(8):694-702. PubMed ID: 26942997 [TBL] [Abstract][Full Text] [Related]
5. The clinical applications of curcumin: current state and the future. Fan X; Zhang C; Liu DB; Yan J; Liang HP Curr Pharm Des; 2013; 19(11):2011-31. PubMed ID: 23116310 [TBL] [Abstract][Full Text] [Related]
6. Preparation and characterization of water-soluble albumin-bound curcumin nanoparticles with improved antitumor activity. Kim TH; Jiang HH; Youn YS; Park CW; Tak KK; Lee S; Kim H; Jon S; Chen X; Lee KC Int J Pharm; 2011 Jan; 403(1-2):285-91. PubMed ID: 21035530 [TBL] [Abstract][Full Text] [Related]
7. Curcumin nanoformulations: a review of pharmaceutical properties and preclinical studies and clinical data related to cancer treatment. Naksuriya O; Okonogi S; Schiffelers RM; Hennink WE Biomaterials; 2014 Mar; 35(10):3365-83. PubMed ID: 24439402 [TBL] [Abstract][Full Text] [Related]
8. Curcumin nanomedicine: a road to cancer therapeutics. Yallapu MM; Jaggi M; Chauhan SC Curr Pharm Des; 2013; 19(11):1994-2010. PubMed ID: 23116309 [TBL] [Abstract][Full Text] [Related]
9. Neuroprotective Effects and Mechanisms of Curcumin-Cu(II) and -Zn(II) Complexes Systems and Their Pharmacological Implications. Yan FS; Sun JL; Xie WH; Shen L; Ji HF Nutrients; 2017 Dec; 10(1):. PubMed ID: 29283372 [TBL] [Abstract][Full Text] [Related]
10. Liposomal curcumin and its application in cancer. Feng T; Wei Y; Lee RJ; Zhao L Int J Nanomedicine; 2017; 12():6027-6044. PubMed ID: 28860764 [TBL] [Abstract][Full Text] [Related]
11. Perspectives on new synthetic curcumin analogs and their potential anticancer properties. Vyas A; Dandawate P; Padhye S; Ahmad A; Sarkar F Curr Pharm Des; 2013; 19(11):2047-69. PubMed ID: 23116312 [TBL] [Abstract][Full Text] [Related]
12. Pharmaceutical strategies of improving oral systemic bioavailability of curcumin for clinical application. Ma Z; Wang N; He H; Tang X J Control Release; 2019 Dec; 316():359-380. PubMed ID: 31682912 [TBL] [Abstract][Full Text] [Related]
13. In vitro study on potential pharmacological activity of curcumin analogues and their copper complexes. Ferrari E; Benassi R; Saladini M; Orteca G; Gazova Z; Siposova K Chem Biol Drug Des; 2017 Mar; 89(3):411-419. PubMed ID: 27569739 [TBL] [Abstract][Full Text] [Related]
14. Multiple biological activities of curcumin: a short review. Maheshwari RK; Singh AK; Gaddipati J; Srimal RC Life Sci; 2006 Mar; 78(18):2081-7. PubMed ID: 16413584 [TBL] [Abstract][Full Text] [Related]
15. Analysis of different innovative formulations of curcumin for improved relative oral bioavailability in human subjects. Purpura M; Lowery RP; Wilson JM; Mannan H; Münch G; Razmovski-Naumovski V Eur J Nutr; 2018 Apr; 57(3):929-938. PubMed ID: 28204880 [TBL] [Abstract][Full Text] [Related]
16. Curcumin: the Indian solid gold. Aggarwal BB; Sundaram C; Malani N; Ichikawa H Adv Exp Med Biol; 2007; 595():1-75. PubMed ID: 17569205 [TBL] [Abstract][Full Text] [Related]
17. Delivery of curcumin by directed self-assembled micelles enhances therapeutic treatment of non-small-cell lung cancer. Zhu WT; Liu SY; Wu L; Xu HL; Wang J; Ni GX; Zeng QB Int J Nanomedicine; 2017; 12():2621-2634. PubMed ID: 28435247 [TBL] [Abstract][Full Text] [Related]
18. Combined therapy using bevacizumab and turmeric ethanolic extract (with absorbable curcumin) exhibited beneficial efficacy in colon cancer mice. Yue GG; Kwok HF; Lee JK; Jiang L; Wong EC; Gao S; Wong HL; Li L; Chan KM; Leung PC; Fung KP; Zuo Z; Lau CB Pharmacol Res; 2016 Sep; 111():43-57. PubMed ID: 27241019 [TBL] [Abstract][Full Text] [Related]
19. Biological and pharmacological evaluation of dimethoxycurcumin: A metabolically stable curcumin analogue with a promising therapeutic potential. Teymouri M; Barati N; Pirro M; Sahebkar A J Cell Physiol; 2018 Jan; 233(1):124-140. PubMed ID: 27996095 [TBL] [Abstract][Full Text] [Related]
20. Curcumin: a boon to colonic diseases. Sareen R; Jain N; Pandit V Curr Drug Targets; 2013 Sep; 14(10):1210-8. PubMed ID: 23768171 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]